Adma Biologics (ADMA) Intangibles (2017 - 2025)
Adma Biologics (ADMA) posted Intangibles of $632000.0 for Q4 2025, up 28.72% on a QoQ basis from $491000.0 in Q3 2025, and up 37.39% year-over-year from $460000.0 in Q4 2024.
Adma Biologics (ADMA) Intangibles (2017 - 2025) Analysis & Trends
Adma Biologics' Intangibles history runs 9 years deep, the most recent figure standing at $632000.0 for Q4 2025.
- Quarterly Intangibles rose 37.39% year-over-year to $632000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $632000.0 (up 37.39% YoY) and the FY2025 annual result came in at $632000.0, up 37.39% from the prior year.
- Intangibles was $632000.0 for Q4 2025 at Adma Biologics, up from $491000.0 in the prior quarter.
- Across five years, Intangibles topped out at $6.1 million in Q1 2021 and bottomed at $321000.0 in Q1 2024.
- A 5-year average of $2.0 million and a median of $745158.5 in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles slumped 90.48% — and 2024, when it surged 743.63%.
- Adma Biologics' Intangibles stood at $1.7 million in 2021, then tumbled by 41.4% to $1.0 million in 2022, then slumped by 50.74% to $499000.0 in 2023, then declined by 7.82% to $460000.0 in 2024, then soared by 37.39% to $632000.0 in 2025.
- Business Quant data shows ADMA's Intangibles at $632000.0 in Q4 2025, $491000.0 in Q3 2025, and $527000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 632,000.00 |
| Sep 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 527,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 460,000.00 |
| Sep 30, 2024 | 485,000.00 |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 321,000.00 |
| Dec 31, 2023 | 499,000.00 |
| Sep 30, 2023 | 476,902.00 |
| Jun 30, 2023 | 655,740.00 |
| Mar 31, 2023 | 834,577.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 5.01 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 5.01 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 6.08 Mn |
| Jun 30, 2021 | 2.09 Mn |
| Mar 31, 2021 | 6.08 Mn |